InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Chan Mitchell. Insider active across 2 companies, notably Avalo Therapeutics, Inc.. Aggregated, 6 disclosures have been recorded. History available since 16 September 2024. The latest transaction was filed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Chan Mitchell is a declarant linked to REGENXBIO Inc., where he is Chief Financial Officer, and to Avalo Therapeutics, Inc., where he is a Director. He has 5 filings in total, and across the 5 recent filings available, the period runs from 2024-09-18 to 2026-03-31, with the modal transaction nature listed as option exercise.